Management of newly diagnosed high-risk and intermediate-risk follicular lymphoma with90Y ibritumomab tiuxetan in a phase II studyNeil L. Berinstein,Nancy M. Pennell,Rashmi Weerasinghe,Rena Buckstein,Eugenia Piliotis,Kevin R. Imrie,Lisa Chodirker, Mary-Anne Cussen,Ellen Miles,Marciano D. Reis,Zeina Ghorab,Matthew C. CheungHematological Oncology(2018)引用 3|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要